Regulation of ribosome biogenesis during the cell cycle, stress and cellular transformation
细胞周期、应激和细胞转化过程中核糖体生物发生的调节
基本信息
- 批准号:G0501666/1
- 负责人:
- 金额:$ 45.21万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2006
- 资助国家:英国
- 起止时间:2006 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
One basic feature of cells is their ability to grow and divide. The production of proteins, essential cell components that represent a significant proportion of the cell mass, is essential for cell growth. The ribosome is a molecular factory in the cell responsible for the synthesis of proteins. The cell regulates protein production by changing the activity and/or the levels of ribosomes. In cell transformation, the initial stage in the generation of tumours, the basic regulation of cell growth and division is lost allowing the cell to continue growing unchecked. It has recently been shown that many proteins that either cause or regulate cancer are also linked to the regulation of protein synthesis in the cell. This often involves the regulation of the synthesis of new ribosomes in a specific compartment in the cell known as the nucleolus. The production of the ribosome is a highly complicated process that is at present poorly understood. The cell has natural tumour suppressive agents such as the protein p53. The activation of this protein inhibits cell growth and division and is linked to the function of the nucleolus. We have found that chemical inhibitors that activate p53 also block the production of ribosomes. We propose to investigate the mechanisms by which these inhibitors block to production of ribosomes. The information gained from this approach will provide important information on how the cell activates the tumour suppressor p53. This research will provide important information on how the cell regulates cell growth and division and should provide new targets for anti-cancer therapeutics.
细胞的一个基本特征是它们生长和分裂的能力。蛋白质的产生是细胞生长所必需的,蛋白质是细胞的基本成分,占细胞质量的很大比例。核糖体是细胞中负责蛋白质合成的分子工厂。细胞通过改变核糖体的活性和/或水平来调节蛋白质的产生。在细胞转化中,即肿瘤产生的初始阶段,细胞生长和分裂的基本调节丧失,允许细胞继续不受抑制地生长。最近的研究表明,许多引起或调节癌症的蛋白质也与细胞中蛋白质合成的调节有关。这通常涉及细胞中称为核仁的特定隔室中新核糖体合成的调节。核糖体的产生是一个非常复杂的过程,目前人们对这个过程还知之甚少。该细胞具有天然的肿瘤抑制剂,如蛋白质p53。这种蛋白质的激活抑制细胞生长和分裂,并与核仁的功能有关。我们发现激活p53的化学抑制剂也会阻断核糖体的产生。我们建议研究这些抑制剂阻断核糖体产生的机制。从这种方法中获得的信息将提供有关细胞如何激活肿瘤抑制因子p53的重要信息。这项研究将为细胞如何调节细胞生长和分裂提供重要信息,并为抗癌治疗提供新的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas Watkins其他文献
Clinical and genetic evidence and population evidence
临床和遗传证据以及人群证据
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
G. Charames;P. J. Sabatini;Nicholas Watkins - 通讯作者:
Nicholas Watkins
Implementing Next-Generation Sequencing in Clinical Practice.
在临床实践中实施下一代测序。
- DOI:
10.1373/jalm.2017.025791 - 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Nicholas Watkins;G. Charames - 通讯作者:
G. Charames
eP374: Variant classification changes over time at a clinical molecular diagnostic laboratory
- DOI:
10.1016/j.gim.2022.01.409 - 发表时间:
2022-03-01 - 期刊:
- 影响因子:
- 作者:
Chloe Mighton;Andrew Wong;Vanessa Di Gioacchino;Nicholas Watkins;Justin Mayers;Yvonne Bombard;George Charames;Jordan Lerner-Ellis - 通讯作者:
Jordan Lerner-Ellis
emInhibition of MRP1 Induces Fetal Hemoglobin through NRF2 Activation to Protect Human Erythroid Cells from Sickling/em
MRP1 的抑制通过 NRF2 激活诱导胎儿血红蛋白以保护人类红细胞免于镰状化
- DOI:
10.1182/blood-2022-168169 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:23.100
- 作者:
Yannis Hara;Emily Kawabata;Viktor T. Lemgart;Paola G. Bronson;Alexandra Hicks;Sriram Krishnamoorthy;Nicholas Watkins;Robert Peters;David J. Roberts;Emanuele Di Angelantonio;John Danesh;William Astle;Dirk S. Paul;Samuel Lessard;Adam S. Butterworth - 通讯作者:
Adam S. Butterworth
Validation of low‐pass genome sequencing for prenatal diagnosis
产前诊断低通基因组测序的验证
- DOI:
10.1002/pd.6525 - 发表时间:
2024 - 期刊:
- 影响因子:3
- 作者:
Chloe Mighton;Abdul Noor;Nicholas Watkins;Vanessa Di Gioacchino;J. Lerner;Andrew Wong;Elvira Mukharryamova;Nina Anggala;D. Chitayat;E. Greenfeld - 通讯作者:
E. Greenfeld
Nicholas Watkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas Watkins', 18)}}的其他基金
A molecular scaffold that mediates box C/D snoRNP biogenesis
介导框 C/D snoRNP 生物发生的分子支架
- 批准号:
BB/F006853/1 - 财政年份:2008
- 资助金额:
$ 45.21万 - 项目类别:
Research Grant
相似国自然基金
UMSC-Exo通过调控Ribosome biogenesis诱导心肌再生的策略及机制研究
- 批准号:82370264
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Non-coding RNA regulation of neuronal protein translation and appetite control
非编码RNA调节神经元蛋白质翻译和食欲控制
- 批准号:
10751087 - 财政年份:2023
- 资助金额:
$ 45.21万 - 项目类别:
EpoR & Stat5 regulation of ribosome biogenesis and protein synthesis in erythropoiesis
EPR
- 批准号:
10682214 - 财政年份:2023
- 资助金额:
$ 45.21万 - 项目类别:
Regulation of Protein Synthesis in Leukemia Stem Cells
白血病干细胞中蛋白质合成的调控
- 批准号:
10801320 - 财政年份:2023
- 资助金额:
$ 45.21万 - 项目类别:
Mechanisms of RNA localization and translational regulation on the endoplasmic reticulum
内质网RNA定位和翻译调控机制
- 批准号:
10460908 - 财政年份:2021
- 资助金额:
$ 45.21万 - 项目类别:
Mechanisms of RNA localization and translational regulation on the endoplasmic reticulum
内质网RNA定位和翻译调控机制
- 批准号:
10667577 - 财政年份:2021
- 资助金额:
$ 45.21万 - 项目类别:
Mechanisms of regulation of ribosome biogenesis and stress resistance in yeast
酵母核糖体生物发生和抗逆性的调控机制
- 批准号:
RGPIN-2015-06400 - 财政年份:2021
- 资助金额:
$ 45.21万 - 项目类别:
Discovery Grants Program - Individual
Translational regulation of PGC1alpha and oxidative metabolism
PGC1α 和氧化代谢的翻译调控
- 批准号:
10399645 - 财政年份:2021
- 资助金额:
$ 45.21万 - 项目类别:
Translational regulation of PGC1alpha and oxidative metabolism
PGC1α 和氧化代谢的翻译调控
- 批准号:
10214944 - 财政年份:2021
- 资助金额:
$ 45.21万 - 项目类别:
Exploiting a novel role for BRCA1 in the regulation of Pol II-dependent ribosome biogenesis
利用 BRCA1 在 Pol II 依赖性核糖体生物合成调节中的新作用
- 批准号:
439358 - 财政年份:2020
- 资助金额:
$ 45.21万 - 项目类别:
Studentship Programs














{{item.name}}会员




